
ASTELLAS PHARMA INC by Astellas Pharma rose 43.4% from $12.20 to $17.50, ahead of the S&P 500's +9.7%. Its worst day was Oct 30 (−18.0%), and its low came Nov 24 at $11.40.
Nov 20, 2025 – Nov 19, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
ASTELLAS PHARMA INC by Astellas Pharma closed at its lowest level of the year, 6.6% below where the year started.
−10.4% · S&P 500 +1.5%
ASTELLAS PHARMA INC by Astellas Pharma closed at its highest level of the year, 44.3% above where the year started.
Story events cover the past 12 months · Times ET
+9.0% · S&P 500 +0.1%
ASTELLAS PHARMA INC by Astellas Pharma shares rose 18.1%, while the S&P 500 rose 1.2%.
+18.1% · S&P 500 +1.2%
ASTELLAS PHARMA INC by Astellas Pharma shares rose 23.0%, while the S&P 500 rose 0.6%.
+23.0%, the year's best day · S&P 500 +0.6%
ASTELLAS PHARMA INC by Astellas Pharma shares rose 18.3%, while the S&P 500 rose 0.4%.
+18.3% · S&P 500 +0.4%
Where it ended: a close of $17.50 on Nov 19, 2026.
Nothing in the past 12 months.
All ALPMF earningsNothing in the past 12 months.
All ALPMF analyst actionsNothing in the past 12 months.
All ALPMF dividend history